![](/img/cover-not-exists.png)
A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Chung, C. H., Lee, J. W., Slebos, R. J., Howard, J. D., Perez, J., Kang, H., Fertig, E. J., Considine, M., Gilbert, J., Murphy, B. A., Nallur, S., Paranjape, T., Jordan, R. C., Garcia, J., Burtness, BVolume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu367
Date:
November, 2014
File:
PDF, 199 KB
english, 2014